Creative Medical Technology Holdings (CELZ) Return on Sales [ROS] (2017 - 2026)
Creative Medical Technology Holdings (CELZ) reported Return on Sales [ROS] of -208004.40% for Q2 2026, down 109347.63 percentage points from -98656.77% a year earlier and down 9954.77 percentage points from the prior quarter.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
For FY2025, Creative Medical Technology Holdings posted Return on Sales [ROS] of -102380.23%, down 50163.32 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of -101702.52 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -52216.92% in FY2024 (+10228.99 pp), -62445.91% in FY2023 (-50883.41 pp), -11562.50% in FY2022 (-8000.32 pp) and -3562.17% in FY2021 (-2884.46 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q4 2017.
- Year over year, Return on Sales [ROS] has now declined in each of the last five quarters, with an average year-over-year change of -50579.70 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2025 (a gain of 7208.61 percentage points); the low point was Q1 2026 (a drop of 142700.37 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -198049.63% (Q1 2026), -64859.40% (Q4 2025) and -101379.43% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Creative Medical Technology Holdings | 1.26 Mn | 1.29 Mn | - | -208,004.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -208,004.40% |
| Mar 31, 2026 | -198,049.63% |
| Dec 31, 2025 | -64,859.40% |
| Sep 30, 2025 | -101,379.43% |
| Jun 30, 2025 | -98,656.77% |
| Mar 31, 2025 | -55,349.27% |
| Dec 31, 2024 | -62,857.80% |
| Sep 30, 2024 | -51,181.51% |
| Jun 30, 2024 | -20,316.33% |
| Mar 31, 2024 | -62,557.88% |
| Dec 31, 2023 | -59,061.30% |
| Sep 30, 2023 | -25,719.75% |
| Jun 30, 2023 | -13,048.19% |
| Mar 31, 2023 | -13,862.19% |
| Dec 31, 2022 | -33,752.35% |
| Sep 30, 2022 | -1,855.31% |
| Jun 30, 2022 | -5,662.48% |
| Mar 31, 2022 | -7,699.13% |
| Dec 31, 2021 | -2,173.64% |
| Sep 30, 2021 | -8,334.36% |
API Access
Creative Medical Technology Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CELZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CELZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CELZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();